Readmissions and Mortality During the First Year After Stroke-Data From a Population-Based Incidence Study

被引:15
|
作者
Abreu, Pedro [1 ,2 ]
Magalhaes, Rui [3 ]
Baptista, Diana [2 ]
Azevedo, Elsa [1 ,2 ]
Silva, Maria Carolina [3 ]
Correia, Manuel [3 ,4 ]
机构
[1] Ctr Hosp Univ Sao Joao, Dept Neurol, Porto, Portugal
[2] Univ Porto, Fac Med, Dept Clin Neurosci & Mental Hlth, Porto, Portugal
[3] Univ Porto, Inst Ciencias Biomed Abel Salazar, Porto, Portugal
[4] Ctr Hosp Univ Porto, Dept Neurol, Hosp Santo Antonio, Porto, Portugal
来源
FRONTIERS IN NEUROLOGY | 2020年 / 11卷
关键词
stroke readmissions; epidemiology; outcome; mortality; community-based study; ACUTE ISCHEMIC-STROKE; HOSPITAL READMISSION; PREVENTABLE READMISSIONS; INTRACEREBRAL HEMORRHAGE; NORTHERN PORTUGAL; RISK-FACTORS; PREDICTORS; CLASSIFICATION; KNOWLEDGE; AWARENESS;
D O I
10.3389/fneur.2020.00636
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background:After a first-ever-in-a-lifetime stroke (FELS), hospital readmissions are common and associated with increased mortality and morbidity of stroke survivors, thus, raising the overall health burden of stroke. Population-based stroke studies on hospital readmissions are scarce despite it being an important healthcare service quality indicator. We evaluated unplanned readmissions or death during the first year after a FELS and their potential factors, based on a Portuguese community register. Methods:Data were retrieved from a population-based prospective register undertaken in Northern Portugal (ACIN2) in 2009-2011. Retrospective information about unplanned hospital readmissions and case fatality within 1 year after FELS index hospitalization (FELS-IH) was evaluated. Readmission/death-free survival 1 year after discharge was estimated using the Kaplan-Meyer method. Independent risk factors for readmission/death were identified using Cox proportional hazard models. Results:Unplanned readmission/death within 1 year occurred in 120 (31.6%) of the 389 hospitalized FELS survivors. In 31.2% and 33.5% of the cases, it occurred after ischemic stroke or intracerebral hemorrhage, respectively. Infections and cerebrovascular and cardiovascular diseases were the main causes of readmission. Of the readmissions, 65.3% and 52.5% were potentially avoidable or stroke related, respectively. The main cause of potentially avoidable readmissions was the continuation/recurrence of the event responsible for the initial admission or a closely related condition (71.2%). Male sex, age, previous and post-stroke functional status, and FELS-IH length of stay were independent factors of readmission/death within 1 year. Conclusions:Almost one-third of FELS survivors were readmitted/dead 1 year after their FELS-IH. This outcome persisted after the first months after stroke hospitalization in all stroke subtypes. More than half of readmissions were considered potentially avoidable or stroke related.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Incidence and mortality of ALS: a 42-year population-based nationwide study
    Levison, Lotte Sahin
    Blicher, Jakob Udby
    Andersen, Henning
    JOURNAL OF NEUROLOGY, 2025, 272 (01)
  • [32] Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data
    Ciaffi, Jacopo
    Morabito, Maria Francesca
    Ruscitti, Piero
    D'Angelo, Salvatore
    Mancarella, Luana
    Brusi, Veronica
    Abignano, Giuseppina
    Pucino, Valentina
    Giacomelli, Roberto
    Meliconi, Riccardo
    Ursini, Francesco
    RHEUMATOLOGY INTERNATIONAL, 2021, 41 (01) : 129 - 137
  • [33] Elevated Mortality Risk in the First Year Post-Diagnosis of Sarcoidosis: A Comprehensive Population-Based Cohort Study
    Patt, Yonatan Shneor
    Sharif, Kassem
    David, Paula
    Hen, Or
    Gendelman, Omer
    Elizur, Yoav
    Ahmaro, Basel
    Weinstein, Orly
    Watad, Abdulla
    Amital, Howard
    Ben-Shabat, Niv
    MEDICINA-LITHUANIA, 2024, 60 (11):
  • [34] Population-Based Study Detailing Cutaneous Melanoma Incidence and Mortality Trends in Canada
    Conte, Santina
    Ghazawi, Feras M.
    Le, Michelle
    Nedjar, Hacene
    Alakel, Akram
    Lagace, Francois
    Mukovozov, Ilya M.
    Cyr, Janelle
    Mourad, Ahmed
    Miller Jr, Wilson H. H.
    Claveau, Joel
    Salopek, Thomas G.
    Netchiporouk, Elena
    Gniadecki, Robert
    Sasseville, Denis
    Rahme, Elham
    Litvinov, Ivan V.
    FRONTIERS IN MEDICINE, 2022, 9
  • [35] Incidence, Prevalence, and Mortality of Dermatomyositis: A Population-Based Cohort Study
    Kronzer, Vanessa L.
    Kimbrough, Bradly A.
    Crowson, Cynthia S.
    Davis, John M., III
    Holmqvist, Marie
    Ernste, Floranne C.
    ARTHRITIS CARE & RESEARCH, 2023, 75 (02) : 348 - 355
  • [36] Incidence, prevalence, and mortality of sarcoidosis in England: a population-based study
    Bechman, Katie
    Russell, Mark D.
    Biddle, Kathryn
    Gibson, Mark
    Adas, Maryam
    Yang, Zijing
    Patel, Samir
    Dregan, Alex
    Walsh, Sarah
    Brex, Peter
    Patel, Amit
    Myall, Katherine J.
    Norton, Sam
    Birring, Surinder S.
    Galloway, James
    LANCET REGIONAL HEALTH-EUROPE, 2025, 53
  • [37] Stroke mortality in cancer survivors: A population-based study in Japan
    Gon, Yasufumi
    Zha, Ling
    Sasaki, Tsutomu
    Morishima, Toshitaka
    Ohno, Yuko
    Mochizuki, Hideki
    Sobue, Tomotaka
    Miyashiro, Isao
    THROMBOSIS RESEARCH, 2023, 222 : 140 - 148
  • [38] 30-Year Mortality After Venous Thromboembolism A Population-Based Cohort Study
    Sogaard, Kirstine Kobberoe
    Schmidt, Morten
    Pedersen, Lars
    Horvath-Puho, Erzsebet
    Sorensen, Henrik Toft
    CIRCULATION, 2014, 130 (10) : 829 - 836
  • [39] Incidence and outcome of epilepsy syndromes with onset in the first year of life: A retrospective population-based study
    Gaily, Eija
    Lommi, Markus
    Lapatto, Risto
    Lehesjoki, Anna-Elina
    EPILEPSIA, 2016, 57 (10) : 1594 - 1601
  • [40] The first three years of the Swiss NeuroPaediatric Stroke Registry (SNPSR):: A population-based study of incidence, symptoms and risk factors
    Steinlin, M
    Pfister, I
    Pavlovic, J
    Everts, R
    Boltshauser, E
    Mori, AC
    Mercati, DG
    Hänggeli, CA
    Keller, E
    Luetschg, J
    Marcoz, J
    Ramelli, GP
    Perez, ER
    Schmitt-Mechelke, T
    Weissert, M
    NEUROPEDIATRICS, 2005, 36 (02) : 90 - 97